NAME: DOMINIQUE CHAUVEAU
|
DOB March 6, 1959 | |
|
ADDRESS |
Department of Nephrology and Clinical Immunology |
|
CHU de Rangueil, 1 avenue Jean Poulhès, | |
| 31059 Toulouse Cedex 9, | |
| France | |
| Phone : +335 6132 3279 Fax : +335 6132 2351 | |
|
E-mail: |
|
|
EDUCATION
| |
|
1982 |
MD, University Paris-5 |
| 1989 | Specialist in Nephrology, University Paris-5 |
| 1989 | Master for Cardiovascular Pharmacology, University Lyon-1, France |
| 1998 | Sabbatical leave, Institute of Molecular Medicine, University of Oxford, UK |
| 2003 | Ph D, Medical Sciences, University Paris-5, France |
|
PROFESSIONAL APPOINTMENTS | |
| 1989-1992 | Chief of Clinic, Department of Nephrology, Necker Hospital, Paris |
1992-2004 |
Lecturer, Department of Nephrology, Necker Hospital, Paris |
| 2004-2005 | Lecturer, Department of Nephrology & Clinical Immunology, Rangueil Hospital, Toulouse |
| 2005-present: | |
| Professor of Nephrology, University Paul Sabatier & Department of Nephrology and Clinical Immunology, Rangueil Hospital, Toulouse; | |
| Coordinator, Reference Center for Orphan Kidney Diseases, Toulouse | |
SCIENTIFIC AREAS OF INTEREST | |
Inherited renal diseases |
|
|
1989-2002 |
Genetic basis for cerebral aneurysms in ADPKD |
|
2002-2005 |
Adult phenotype of renal involvement in mitochondrial cytopathies (3243A>G) |
| 2004- | TCF2/HNF-1b-related nephropathy : phenotype in adulthood ; elucidation of gene network in human |
MEMBERSHIP IN ACADEMIC/SCIENTIFIC/ADMINISTRATIVE ACTIVITIES: | |
Faculty &Hospital |
|
1998-2002 Board member, Medical Council, Necker Hospital, Paris, France |
|
2007- Council member, Faculty of Medicine, Toulouse |
|
Scientific societies |
|
1999-present General Secretary, Société de Néphrologie (French Society of Nephrology) |
|
Membership scientific societies |
|
| European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) | |
| International Society of Nephrology(ISN) | |
| American Society of Nephrology (ASN) | |
| Societé d'hypertension arérielle (French Society of Hypertention) | |
Advisory activities |
|
1999-present Expert contribution to National Health Agencies (ANAES, AFSSAPS) |
|
Editorial scientific activities |
|
Ad hoc Reviewer Nephrol Dial Transplant, Kidney Int, J Am Soc Nephrol
| |
2004-present Member, Editorial Board, Néphrologie et Thérapeutique |
|
|
PUBLICATIONS | |
88 original, peer review publications |
|
25 reviews and editorials |
|
| 22 book chapters | |
|
| |
|
| |
|
SELECTED PUBLICATIONS: | |
Bellanné-Chantelot C, Clauin S, Chauveau D et al. Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5. Diabetes. 2005, 54 : 3126-32. |
|
Rebouissou S, Vassiliu V, Thomas C, Bellanné-Chantelot C, Bui H, Timsit J, Chauveau D, Zucman-Rossi Germline mutations and inactivation of HNF-1ß in chromophobe renal cell carcinomas. J. Hum Mol Genet, 2005, 14 : 603-614. |
|
Rychlík I, Petrtýl J, Tesař V, Stejskalová A, Žabka J, Brůha R: Transjugular renal biopsy - our experience with 67 cases. Kidney Blood Press Res 2001; 24: 207-212. |
|
Bellanné-Chantelot C, Chauveau D, Gautier JF, Dubois-Laforgue D, Clauin S, Beaufils S, Wilhelm JM, Boitard C, Noël LH, Velho G, Timsit J. Multiple organ involvement in maturity-onset diabetes of the young related to hepatocyte nuclear factor-1b. Ann Intern Med, 2004, 140: 510-517 |
|
Guéry B, Choukroun G, Noël LH, Pierre Clavel P, Rötig A, Bellané-Chantelot C, Mougenot B, Grünfeld JP, Chauveau D. The spectrum of systemic involvement in adults presenting with renal lesion and mitochondrial tRNA(Leu) gene mutation. J Am Soc Nephrol 2003, 14: 2099-108 |
|
| Rossetti S, Chauveau D, Kubly V, Slezak JM, Saggar-Malik A, Pei Y, Ong ACM, Stewart F, Watson ML, Bergstralh EJ, Winearls CG, Torres VE, Harris PC. Association of mutation position in the polycystic kidney disease 1 (PKD1) and the development of a vascular phenotype. Lancet, 2003, 361: 2196-201. |
|
Pirson Y, Chauveau D, Torres V. Management of intracranial aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol, 2002, 13: 269-276. |
|
Rossetti S, Chauveau D, Walker D, Sagar-Malik A, Winearls CG, Torres VE, Harris PC. A complete mutation screen of the ADPKD genes by DHPLC. Kidney Int, 2002, 61: 1588-1599. |
|
Chauveau D, Pirson Y, Verellen-Dumoulin C, Macnicol A, Gonzalo A, Grünfeld JP. Intracranial aneurysms in autosomal dominant polycystic kidney disease. Kidney Int, 1994, 45: 1140-46. |
|
ChaUveau D, Fakhouri F, Grünfeld JP. Liver involvement in autosomal-dominant polycystic kidney disease:therapeutic dilemma. J Am Soc Nephrol 2000, 11 : 1767-1775 |
|
Tricot L, Yahiaoui Y, Teixeira L, Benabdallah L, Rothschild E, Juquel JP, Satre V, Grunfeld JP, Chauveau D. End-stage renal failure in Lowe syndrome. Nephrol Dial Transplant. 2003, 18: 1923-5. |
|
Persu A, El-Khattabi O, Messiaen T, Pirson Y, Chauveau D, Devuyst O. Influence of ACE (I/D) and G460W polymorphism of alpha-adducin in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2003, 18: 2032-8. |
|